Literature DB >> 27848931

Serum Albumin and C-Reactive Protein/Albumin Ratio Are Useful Biomarkers of Crohn's Disease Activity.

Guangming Qin1, Jiangfeng Tu2, Lingang Liu2, Laisheng Luo2, Jiaqi Wu2, Lisha Tao2, Chenjing Zhang2, Xiaoge Geng2, Xiaojun Chen2, Xinbo Ai3, Bo Shen4, Wensheng Pan2.   

Abstract

BACKGROUND Serum albumin (ALB) may be low during acute inflammation, but it is also affected by nutritional status. Therefore, we hypothesized that ALB and the C-reactive protein/ALB ratio (CRP/ALB) may be associated with disease activity in patients with Crohn's disease (CD). MATERIAL AND METHODS Altogether, 100 patients with CD and 100 age- and sex-matched healthy volunteers were retrospectively enrolled in the current study. The patients with CD were subdivided into patients with active disease (Crohn's Disease Activity Index >150) and those in remission. ALB levels, CRP levels, and lipid profiles were measured. RESULTS ALB and CRP levels and the CRP/ALB ratio were the most useful for differentiating between active and nonactive CD. ALB levels (r=-0.50, P<0.01), CRP levels (r=0.39, P<0.01), and CRP/ALB ratio (r=0.42, P<0.01) all correlated with CD activity. These correlations were more prominent in males. Receiver Operating Characteristic (ROC) analysis indicated that the area under the curve (AUC) representing ALB (0.79) was higher than the AUC representing CRP (0.73) or CRP/ALB ratio (0.75; P>0.05). The AUCs corresponding to ALB level, CRP level, and CRP/ALB ratio were more prominent in males versus females (P<0.05). CRP level (14.55 mg/L), ALB level (34.35 g/L), and CRP/ALB ratio (0.69) had sensitivities of 67.7%, 72.6%, and 59.7%, and specificities of 73.7%, 78.9%, and 81.6%, respectively, for CD activity. CONCLUSIONS In the present retrospective study, we found that ALB level and CRP/ALB ratio were useful biomarkers for identifying CD activity, especially in males. These results suggest that, in addition to inflammation, assessment of patient nutritional status could also aid in identifying CD activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27848931     DOI: 10.12659/msm.897460

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  32 in total

1.  Risk of postoperative morbidity in patients having bowel resection for colonic Crohn's disease.

Authors:  Igors Iesalnieks; A Spinelli; M Frasson; F Di Candido; B Scheef; N Horesh; M Iborra; H J Schlitt; A El-Hussuna
Journal:  Tech Coloproctol       Date:  2018-12-12       Impact factor: 3.781

2.  C-reactive protein-to-albumin ratio and 8-year incidence of type 2 diabetes: the Korean genome and epidemiology study.

Authors:  A-Ra Cho; Sung-Bum Lee; Kyung-Won Hong; Dong-Hyuk Jung
Journal:  Acta Diabetol       Date:  2021-06-15       Impact factor: 4.280

3.  Elderly-onset Crohn's disease remarkably responsive to ustekinumab: a case report.

Authors:  Maho Iwamoto; Kimitoshi Kato; Mitsuhiko Moriyama
Journal:  Int J Colorectal Dis       Date:  2019-12-17       Impact factor: 2.571

4.  C-reactive protein/albumin ratio as an indicator of disease activity in Behçet's disease and human leukocyte antigen-B27-associated uveitis.

Authors:  Mirinae Kim; Young-Gun Park; Young-Hoon Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-30       Impact factor: 3.117

5.  Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell's palsy?

Authors:  Serkan Cayir; Omer Hizli; Serkan Kayabasi
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-16       Impact factor: 2.503

6.  Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life.

Authors:  İsmihan Sunar; Şebnem Ataman
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

Review 7.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

8.  Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.

Authors:  Masaaki Murakawa; Naoto Yamamoto; Yuto Kamioka; Mariko Kamiya; Satoshi Kobayashi; Makoto Ueno; Manabu Morimoto; Yosuke Atsumi; Toru Aoyama; Hiroshi Tamagawa; Norio Yukawa; Yasushi Rino; Munetaka Masuda; Soichiro Morinaga
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

9.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Authors:  Remo Panaccione; A Hillary Steinhart; Brian Bressler; Reena Khanna; John K Marshall; Laura Targownik; Waqqas Afif; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams; Charles N Bernstein
Journal:  J Can Assoc Gastroenterol       Date:  2018-07-10

Review 10.  Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Authors:  A Hillary Steinhart; Remo Panaccione; Laura Targownik; Brian Bressler; Reena Khanna; John K Marshall; Waqqas Afif; Charles N Bernstein; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams
Journal:  J Can Assoc Gastroenterol       Date:  2018-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.